Resources

Mayo Clinic Store

Web sites

Oct. 04, 2016
References
  1. Markey KA, et al. Understanding idiopathic intracranial hypertension: Mechanisms, management, and future directions. Lancet Neurology. 2016;15:78.
  2. Ferri FF. Idiopathic intracranial hypertension . In: Ferri's Clinical Advisor 2017. Philadelphia, Pa.: Mosby Elsevier; 2017. https://www.clinicalkey.com. Accessed Aug. 8, 2016.
  3. Idiopathic intracranial hypertension (pseudotumor cerebri). American Association for Pediatric Ophthalmology and Strabismus. https://www.aapos.org/terms/conditions/59. Accessed Aug. 8, 2016.
  4. Lee AG, et al. Idiopathic intracranial hypertension (pseudotumor cerebri): Epidemiology and pathogenesis. http://www.uptodate.com/home. Accessed Aug. 8, 2016.
  5. NINDS pseudotumor cerebri information page. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/pseudotumorcerebri/pseudotumorcerebri.htm. Accessed Aug. 8, 2016.
  6. Lee AG, et al. Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis. http://www.uptodate.com/home. Accessed Aug. 8, 2016.
  7. Lee AG, et al. Idiopathic intracranial hypertension (pseudotumor cerebri): Prognosis and treatment. http://www.uptodate.com/home. Accessed Aug. 8, 2016.